RhumbLine Advisers’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,500
Closed -$356K 2994
2015
Q4
$356K Buy
3,500
+200
+6% +$22.5K ﹤0.01% 2463
2015
Q3
$589K Hold
3,300
﹤0.01% 2116
2015
Q2
$733K Sell
3,300
-818
-20% -$181K ﹤0.01% 2081
2015
Q1
$818K Sell
4,118
-182
-4% -$32.3K ﹤0.01% 1984
2014
Q4
$615K Hold
4,300
﹤0.01% 2150
2014
Q3
$564K Sell
4,300
-100
-2% -$11.9K ﹤0.01% 2132
2014
Q2
$555K Buy
4,400
+300
+7% +$38.3K ﹤0.01% 2207
2014
Q1
$541K Buy
4,100
+200
+5% +$27.3K ﹤0.01% 2171
2013
Q4
$458K Buy
+3,900
New +$427K ﹤0.01% 2307

Other funds holding BHC

RhumbLine Advisers's BHC Position: Q1 2016 in Review

RhumbLine Advisers sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 3,500 shares — an estimated $356K sold.

RhumbLine Advisers first reported a position in BHC in Q4 2013 and held it in 9 quarters. The position peaked at $818K in Q1 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • RhumbLine Advisers reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • RhumbLine Advisers sold 3,500 Bausch Health shares in Q1 2016, an estimated $356K.
  • RhumbLine Advisers first reported a position in Bausch Health in Q4 2013 and held it in 9 quarters.
  • RhumbLine Advisers's Bausch Health position peaked at $818K in Q1 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.